5 assets in Pneumonia

Therapeutic assets addressing Pneumonia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ap-Pa02 Pneumonia	Armata Pharmaceuticals, Inc.	P2	BB (69)
Amikacin Pneumonia	Asian Institute of Gastroenterology, India	P4	B (61)
Aon-D21 Pneumonia	Aptarion Biotech AG	P2	B (57)
Montanide Isa 51 Pneumonia	Roswell Park Cancer Institute	Early P1	CC (43)
Recombinant Human Egf-Rp64K Pneumonia	Roswell Park Cancer Institute	Early P1	CC (43)